PDGFRB and nonpapillary renal cell carcinoma: This inactivation of VHL leads to the upregulation of platelet-derived growth factor receptor β (PDGFRβ), which promotes ccRCC progression and further enhances histone lactylation, creating a self-amplifying cycle of malignancy [40].